Holiga, Stefan; Abdulkadir, Ahmed; Klöppel, Stefan; Dukart, Juergen (2018). Functional Magnetic Resonance Imaging in Alzheimer' Disease Drug Development. In: Biomarkers for Alzheimer’s Disease Drug Development. Methods in Molecular Biology: Vol. 1750 (pp. 159-163). Springer 10.1007/978-1-4939-7704-8_10
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Current biomarkers in drug development_bookChapter_v2.pdf - Accepted Version Restricted to registered users only Available under License Publisher holds Copyright. Download (287kB) | Request a copy |
|
Text
978-1-4939-7704-8_10.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (256kB) | Request a copy |
While now commonly applied for studying human brain function the value of functional magnetic resonance imaging in drug development has only recently been recognized. Here we describe the different functional magnetic resonance imaging techniques applied in Alzheimer's disease drug development with their applications, implementation guidelines, and potential pitfalls.
Item Type: |
Book Section (Book Chapter) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > University Psychiatric Services > University Hospital of Geriatric Psychiatry and Psychotherapy |
UniBE Contributor: |
Abdulkadir, Ahmed, Klöppel, Stefan |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1940-6029 |
ISBN: |
978-1-4939-7703-1 |
Series: |
Methods in Molecular Biology |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Katharina Klink |
Date Deposited: |
23 Apr 2018 14:54 |
Last Modified: |
05 Dec 2022 15:11 |
Publisher DOI: |
10.1007/978-1-4939-7704-8_10 |
PubMed ID: |
29512071 |
Uncontrolled Keywords: |
Alzheimer’s disease Biomarker Dementia Prevention Treatment fMRI |
BORIS DOI: |
10.7892/boris.112608 |
URI: |
https://boris.unibe.ch/id/eprint/112608 |
Actions (login required)
 |
Edit item |